Eiko LifeSciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 26, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	808	754	674	717	636	403
Market Cap Growth	29.05%	11.94%	-5.99%	12.74%	57.59%	33.32%
Enterprise Value	730	690	647	676	680	398
Last Close Price	53.31	49.74	52.33	51.70	66.24	42.03
PE Ratio	16.71	16.77	31.99	95.35	82.68	57.15
PS Ratio	1.51	1.41	1.79	2.57	3.47	1.59
PB Ratio	1.16	1.08	1.18	1.41	2.16	1.41
P/TBV Ratio	1.18	1.10	1.19	1.41	2.16	1.41
P/FCF Ratio	-	33.02	-	-	15.89	-
P/OCF Ratio	35.39	33.02	23.04	-	15.05	-
EV/Sales Ratio	1.36	1.29	1.72	2.42	3.71	1.57
EV/EBITDA Ratio	8.62	8.20	23.43	41.90	71.21	30.27
EV/EBIT Ratio	9.80	9.33	31.96	71.12	211.29	52.86
EV/FCF Ratio	-	30.20	-	-	17.00	-
Debt / Equity Ratio	0.07	0.07	0.05	-	0.00	0.16
Debt / EBITDA Ratio	0.56	0.56	1.00	-	0.06	3.52
Debt / FCF Ratio	2.07	2.07	-	-	0.01	-
Net Debt / Equity Ratio	-0.13	-0.13	-0.16	-0.26	-0.02	0.15
Net Debt / EBITDA Ratio	-1.06	-1.06	-3.27	-8.27	-0.58	3.35
Net Debt / FCF Ratio	-3.89	-3.89	1.22	1.80	-0.14	-0.56
Asset Turnover	0.69	0.69	0.63	0.67	0.56	0.99
Inventory Turnover	8.47	8.47	7.16	11.84	5.06	8.19
Quick Ratio	2.20	2.20	3.60	17.60	6.44	0.80
Current Ratio	3.08	3.08	5.25	20.56	7.76	2.24
Return on Equity (ROE)	8.40%	8.40%	4.31%	1.88%	2.65%	3.43%
Return on Assets (ROA)	5.95%	5.95%	2.13%	1.42%	0.61%	1.83%
Return on Invested Capital (ROIC)	9.77%	10.16%	3.47%	2.19%	0.78%	2.76%
Return on Capital Employed (ROCE)	10.00%	10.00%	3.40%	1.90%	1.10%	2.60%
Earnings Yield	5.56%	5.96%	3.13%	1.05%	1.21%	1.75%
FCF Yield	-	3.03%	-10.94%	-10.36%	6.29%	-19.54%
Buyback Yield / Dilution	-8.12%	-8.12%	-26.37%	-5.41%	-25.30%	-104.48%
Total Shareholder Return	-8.12%	-8.12%	-26.37%	-5.41%	-25.30%	-104.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.